Here are the top stories from the last week:

Industry Updates

CDC turmoil deepens as Monarez disputes reports of resignation
CDC Director Susan Monarez disputes reports of her resignation, stating she has not resigned nor been notified of termination.
Read article »

The 5 biggest challenges facing retail pharmacy
The article discusses the major challenges facing retail pharmacies, including Medicare price negotiations, reimbursement models for high-cost medications, and operational challenges such as staffing and technology implementation.
Read article »

Sanford Health takes over Lewis Drug after 80 years of family ownership
Sanford Health is set to acquire Lewis Drug, integrating 1,300 employees and188 pharmacists into its system.
Read article »

HDA marks DSCSA implementation milestone for distributors
The Healthcare Distribution Alliance celebrates a milestone in the implementation of the Drug Supply Chain Security Act.
Read article »

Pharmacy insight session examines the latest trends in testing and treatment
A session focused on innovations and strategies in pharmacy-based testing and treatment services.
Read article »

Walgreens’ Laly Havern joins Learn Look Locate to lead Fertility Preservation Education in Breast Cancer
Laly Havern of Walgreens is recognized for her work in oncology and reproductive health, leading new educational initiatives.
Read article »

iA releases Smart SecurePack – Multi
iA has introduced the Smart SecurePack – Multi, an automated packaging solution for multiple prescriptions, aimed at improving efficiency and reducing labor in pharmacy operations.
Read article »

Drug & Treatment Updates

Moderna receives FDA approval for updated COVID-19vaccines
Moderna's updated COVID-19 vaccines, targeting the LP.8.1 variant, have received FDA approval. These vaccines are expected to be available soon and are aimed at individuals at high risk of severe COVID-19 outcomes.
Read article »

FDA approves 2025-2026 version of Novavax COVID-19Vaccine
The FDA has approved the latest version of the Novavax COVID-19 vaccine, updated for current variants.
Read article »

Teva introduces generic Saxenda
Teva has launched a generic version of Saxenda, marking the first generic GLP-1product for weight loss in the U.S. This move is part of Teva's strategy to expand its generics portfolio.
Read article »

FDA gives Biocon unit tentative OK for sitagliptin tablets
The FDA has tentatively approved Biocon's sitagliptin tablets, intended to improve glycemic control in adults with Type 2 diabetes, expanding Biocon's product portfolio.
Read article »

Lilly's oral GLP-1 drug nears global filing
Lilly's new oral GLP-1 drug shows promising results in weight loss and A1C reduction, with global filings planned.
Read article »

‍